Scarica l'app Stockscreener
6.52
1.72%
0.11
Precedente Chiudi:
$6.41
Aprire:
$6.44
Volume 24 ore:
65,689
Relative Volume:
0.10
Capitalizzazione di mercato:
$352.41M
Reddito:
$2.81M
Utile/perdita netta:
$-97.34M
Rapporto P/E:
-4.1266
EPS:
-1.58
Flusso di cassa netto:
$-91.47M
1 W Prestazione:
-1.36%
1M Prestazione:
-16.52%
6M Prestazione:
+96.39%
1 anno Prestazione:
-33.06%
Intervallo 1D:
$6.36
$6.52
Intervallo di 1 settimana:
$6.35
$6.915
Portata 52W:
$2.315
$9.80
Fulcrum Therapeutics Inc Stock (FULC) Company Profile
Nome
Fulcrum Therapeutics Inc
Settore
Industria
Telefono
617-651-8851
Indirizzo
26 LANDSDOWNE STREET, CAMBRIDGE, MA
Confronta FULC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FULC
Fulcrum Therapeutics Inc
|
6.515 | 359.17M | 2.81M | -97.34M | -91.47M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.77 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
583.92 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
698.83 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.04 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Fulcrum Therapeutics Inc Stock (FULC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-29 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-05-23 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-05-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2024-09-13 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-09-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-09-12 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-09-12 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-09-12 | Downgrade | Stifel | Buy → Hold |
| 2024-09-09 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-05-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-09-25 | Iniziato | Goldman | Neutral |
| 2023-08-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-08-22 | Aggiornamento | Stifel | Hold → Buy |
| 2023-05-04 | Downgrade | Goldman | Buy → Neutral |
| 2023-03-10 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-03-10 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-03-09 | Downgrade | Stifel | Buy → Hold |
| 2023-02-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-11-15 | Iniziato | Goldman | Buy |
| 2022-03-08 | Iniziato | Oppenheimer | Outperform |
| 2022-03-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-08-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-03-22 | Iniziato | Credit Suisse | Outperform |
| 2021-03-02 | Iniziato | Stifel | Buy |
| 2020-10-16 | Iniziato | Piper Sandler | Overweight |
| 2020-08-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2020-08-12 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2019-10-03 | Iniziato | H.C. Wainwright | Buy |
| 2019-08-12 | Iniziato | BofA/Merrill | Buy |
Mostra tutto
Fulcrum Therapeutics Inc Borsa (FULC) Ultime notizie
Full technical analysis of Fulcrum Therapeutics Inc. stockJuly 2025 Reactions & Technical Entry and Exit Alerts - Newser
Will Fulcrum Therapeutics Inc. benefit from macro trendsWeekly Trading Summary & Verified Momentum Stock Watchlist - Newser
Will earnings trigger a reversal in Fulcrum Therapeutics Inc.2025 Sector Review & Proven Capital Preservation Methods - Newser
Analyzing Fulcrum Therapeutics Inc. with risk reward ratio chartsJuly 2025 Earnings & Reliable Momentum Entry Alerts - Newser
Building trade automation scripts for Fulcrum Therapeutics Inc.Gold Moves & AI Enhanced Trading Alerts - Newser
Analysts Apply Wyckoff Model to Fulcrum Therapeutics Inc. Stock2025 Investor Takeaways & Reliable Breakout Stock Forecasts - kangso.co.kr
How high can Fulcrum Therapeutics Inc. stock goQuarterly Profit Summary & Daily Volume Surge Signals - Newser
Risk vs reward if holding onto Fulcrum Therapeutics Inc.2025 Volatility Report & Fast Exit and Entry Trade Guides - Newser
What indicators show strength in Fulcrum Therapeutics Inc.Weekly Profit Recap & Safe Entry Trade Reports - Newser
Real time pattern detection on Fulcrum Therapeutics Inc. stockJuly 2025 Catalysts & Reliable Price Action Trade Plans - Newser
Published on: 2025-08-19 17:11:19 - Newser
Is Fulcrum Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Profit Analysis & Reliable Entry Point Trade Alerts - Newser
Applying big data sentiment scoring on Fulcrum Therapeutics Inc.Trade Risk Report & Free Expert Approved Momentum Trade Ideas - Newser
Will earnings trigger a reversal in Fulcrum Therapeutics IncSell Signal & Daily Volume Surge Trade Alerts - Newser
Will Fulcrum Therapeutics Inc. rebound enough to break evenPortfolio Growth Summary & Weekly Top Gainers Alerts - Newser
When is the best time to exit Fulcrum Therapeutics Inc.July 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - Newser
Measuring Fulcrum Therapeutics Inc.’s beta against major indicesPortfolio Gains Report & Verified Stock Trade Ideas - Newser
Using Ichimoku Cloud for Fulcrum Therapeutics Inc. technicalsPortfolio Value Summary & Low Risk Entry Point Tips - Newser
Fulcrum defended at H.C. Wainwright after data for sickle cell disease drug - MSN
Comparing Fulcrum Therapeutics Inc. in custom built stock radarsMarket Movement Recap & Long Hold Capital Preservation Plans - Newser
Is Fulcrum Therapeutics Inc. a Top Dividend Stock to Watch in 2025Stock Surge & Free High Accuracy Swing Entry Alerts - Newser
Chart overlay techniques for tracking Fulcrum Therapeutics Inc.2025 Big Picture & Free Safe Capital Growth Stock Tips - Newser
Forecasting Fulcrum Therapeutics Inc. price range with options dataTreasury Yields & Community Verified Swing Trade Signals - Newser
Quant Models Detect Momentum Reversal in Fulcrum Therapeutics Inc.2025 Trading Volume Trends & Proven Capital Preservation Methods - sundaytimes.kr
What recovery options are there for Fulcrum Therapeutics Inc.Market Growth Summary & Real-Time Volume Trigger Notifications - Newser
Will Fulcrum Therapeutics Inc. Bounce From 52 Week LowTrade Signal Summary & Free Low Drawdown Momentum Trade Ideas - classian.co.kr
XTX Topco Ltd Takes Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World
What makes Fulcrum Therapeutics Inc. stock price move sharplyJuly 2025 Market Mood & Risk Managed Investment Strategies - Newser
Technical signs of recovery in Fulcrum Therapeutics Inc.2025 Trading Volume Trends & Real-Time Market Trend Scan - Newser
Key External Factors That Drive Fulcrum Therapeutics Inc. Stock Price MovementsFree Entry Alert Based on Volume Spikes - Newser
Does Fulcrum Therapeutics Inc. qualify in momentum factor screeningBollinger Band Squeeze and Expansion Analysis - Newser
Fulcrum Therapeutics Inc Azioni (FULC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.72%
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):